Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

6 Pages (Click to Jump) V   1 2 3 4 > »    
 
  
Reply to this topic

IVX, INVION LIMITED
ShareScene.com
post Posted: Sep 7 2012, 11:05 AM
  Quote Post



Posts: 4,290
Thanks: 206


Company name updated -

From: CBIO LIMITED (CBZ)
To: INVION LIMITED (IVX)

Regards, ShareScene.com

 
ktqld
post Posted: Aug 6 2012, 01:14 PM
  Quote Post


Posts: 214


Only one person commenting here on CBZ but I'm posting this just in case it helps someone else who reads this, make a decision re the voting process coming up now. I've been invested in CBIO since 2001 and now feel we have a future to be optimistic about again, IF we all agree to merge CBIO and Inverseon. I've been reading and doing my own research and after receiving the report below (which I've asked and been given permission to post here), feel that a YES vote is the certain future way to head from here. Anyone deliberating should read the due diligence done by Retirewell and also note, that Inverseon has a US$4.4 million grant so shareholders do not need to come up with any money for this. Anyone wanting to phone them for more info please do so - number is at the end of the report.

Retirewell newsletter to CBio Shareholders – 2 August, 2012
CBIO MERGER WITH INVERSEON ‘FAIR AND REASONABLE’

You should have received a Notice of General Meeting and Securityholder Voting Form in the mail from CBio Ltd for a General Meeting to be held at 3 pm on Thursday, 30 August, 2012 at the offices of the company’s lawyers, McCullough Robertson, Level 11, Central Plaza Two, 66 Eagle Street, Brisbane.

This meeting will consider 8 resolutions which, if passed, will effect the proposed merger between CBio and the US pharmaceutical company Inverseon Inc., which was announced to the ASX on 2 July. You also should have received a 106 page Independent Expert’s Report by BDO, which concludes that the merger proposal is “fair and reasonable” to CBio shareholders.

Retirewell also has conducted its own due diligence into the merger proposal by obtaining the opinion of an independent scientific expert, Dr Elliot Israel, Professor of Medicine at Harvard Medical School and Director of Clinical Research, Pulmonary and Critical Care Division at Brigham & Women's Hospital in Boston (one of only two teaching hospitals affiliated with Harvard), who has completed more than 50 studies in asthma.

Dr Israel said he was very familiar with the Inverseon science and knew its President, Dr Mitchell Glass, from way back. He described the Inverseon science as ”very attractive, a unique idea, intriguing and potentially exciting … [with] a significant potential for this to be an effective therapeutic approach. There is a reasonable amount of animal data to show this is a possibility… the studies are supportive [and] there is lot of circumstantial evidence as well.” Dr Israel said Inverseon’s drug could “revolutionise the approach to treating severe asthma in the 10 to 15% of patients who are poorly controlled.”

We are pleased that the merged company, the new name of which will be Invion Ltd, will have the benefit of a US$4.4 million grant from the US Government’s National Institute of Health to fund its Phase II asthma drug trial, which means that shareholders do not have to come up with this money.

We also are pleased that Invion will be conducting a pilot study to treat lupus patients with XToll next year and hope that this will be successful and lead to a licensing and royalty deal with another pharmaceutical company.

We believe that the new management team of Chief Executive Officer, Dr Bill Garner, Executive Vice-President of Research and Development and Chief Medical Officer, Dr Mitchell Glass, and Executive Director, Dr James Campbell, have the necessary expertise and experience to turn this company around and rebuild value for shareholders.

Dr Campbell was a main part of the management team that led ChemGenex Ltd (old ASX: CXS) to be successfully taken over by pharmaceutical giant Cephalon for approximately $230 million in 2011. His and the rest of the new executive team’s experience and connections to “big Pharma” and various institutions will prove invaluable.

Importantly, the majority of the executive and scientific staff will hold shares (escrowed for Inverseon holders) in the new entity and thus are aligned in growing shareholder wealth.

It should be noted that the weekly Australian biotech investment newsletter Bioshares published an article on 13 July recommending that CBio shareholders vote for the merger with Inverseon, which it said was “appealing” for a number of reasons – a lower risk profile for Inverseon’s lead drug, a less expensive clinical development program, Inverseon’s professional management and the fact that the large global markets of asthma and chronic obstructive pulmonary disease are in need of new and superior medicines.

There will be an upcoming investor roadshow and because the merged company will have various promising drugs going into trials and at different stages of development, we expect the news flow to be far more frequent going forward.

We recommend that you vote for all 8 resolutions. The deadline for proxy votes is 3 pm on Tuesday, 28 August. Voting directions are on the Securityholder Voting Form. You can either vote online or by returning the completed and signed form by mail or fax to Link Market Services Ltd.

Vote FOR all 4 resolutions at 2nd General Meeting same day.

CBio Ltd has called a second General Meeting to be held at 4 pm on Thursday, 30 August, 2012 at the offices of the company’s lawyers, McCullough Robertson, Level 11, Central Plaza Two, 66 Eagle Street, Brisbane, straight after the first General Meeting at 3 pm that day.

This meeting will consider 4 “housekeeping” resolutions which, if passed, will ratify the issue of shares and options in connection with previous capital raisings and remove a temporary restriction on the company’s ability to raise capital by way of a placement.

We recommend that you vote for all 4 resolutions. The deadline for proxy votes for this second meeting is 4 pm on Tuesday, 28 August.

Retirewell Financial Planning Pty Ltd
Phone 07 3221 1122
info@retirewell.com.au

IMPORTANT NOTE: The Retirewell e-Newsletter contains general information only. Because the particular circumstances and needs of individual investors may vary greatly, the information herein should not be used as a substitute for personalised professional advice. Whilst every effort has been made to ensure the information is correct, its accuracy and completeness cannot be guaranteed; thus Retirewell cannot be held responsible for any loss suffered by any party due to their reliance on the information or arising from any error or omission. Retirewell Financial Planning Pty Ltd (ABN 29 070 985 509) is the holder of Australian Financial Services Licence No. 247062.

 
plastic
post Posted: Jul 2 2012, 12:03 PM
  Quote Post


Posts: 9,497
Thanks: 285


Well, a RTO of one dog for a probable other.

Whatever happened to those promises of a billion dollar drug. Blockbuster we were told. And then all of a sudden Mr. Streeter ups and walks away from the biggest gravy train ever.

Then all the shennanigans begin.

All I can say is thanks Mr. Streeter.That was my sell signal. graduated.gif



--------------------
What did Uncle Mel do to us?
 
plastic
post Posted: Jun 13 2012, 03:39 PM
  Quote Post


Posts: 9,497
Thanks: 285


Is it time to buy again. Seems to have stabilized. Whats the bet it gets sold for a peppercorn.



--------------------
What did Uncle Mel do to us?
 
plastic
post Posted: Apr 10 2012, 11:50 AM
  Quote Post


Posts: 9,497
Thanks: 285


Looks like the new team are priming the suckers for a shift in direction. The PR out today indicates there are holes in the viability of XToll as a drug. Science apart that spells big bucks. That means more money from the shareholders for an unrisky future.

Don't be surprised if RBS Morgans recommend a trade sale for a peppercorn and reverse an oiler in to the shell.

All I can say is thank you Mr. Streeter. Your exit was the best signal anyone could give.



--------------------
What did Uncle Mel do to us?
 
plastic
post Posted: Feb 15 2012, 02:11 PM
  Quote Post


Posts: 9,497
Thanks: 285


Cooko, why would BI walk away if their product and pipeline were so wonderful?



--------------------
What did Uncle Mel do to us?
 

sentifi.com

Share Cafe Sentifi Top themes and market attention on:


plastic
post Posted: Dec 30 2011, 10:55 AM
  Quote Post


Posts: 9,497
Thanks: 285


QUOTE
One bunch of crooks for another if you ask me


Thanks for the heads up Mr. Streeter. As expected, no deal from Novo Nordisk with a new bunch of crooks to do what they will.



--------------------
What did Uncle Mel do to us?
 
plastic
post Posted: Nov 1 2011, 10:35 AM
  Quote Post


Posts: 9,497
Thanks: 285


In Reply To: chairs's post @ Nov 1 2011, 10:22 AM

Not holding. One bunch of crooks for another if you ask me.

Next signal is to watch what their pharma partner does. Maybe its them behind the bid. Would rather own the company than take up the option.

Doesn't matter. Made a few bucks. Moved on.



--------------------
What did Uncle Mel do to us?
 
chairs
post Posted: Nov 1 2011, 10:22 AM
  Quote Post


Posts: 60


In Reply To: plastic's post @ Sep 6 2011, 09:06 AM

Hi Plastic,
I hope your beans are safe elsewhere mine look at risk, however next Friday will tell - the EXGM to remove directors is on 4/11/2011 - Guy Fawkes could be some fireworks.

Chairs

 
plastic
post Posted: Sep 6 2011, 09:06 AM
  Quote Post


Posts: 9,497
Thanks: 285


While we have talked about takeovers, PIPE's and everything else this company might do in order to take it forward and create value the fact is this rights issue means the current crop of derro-rectors will have lost control of the company. What we are seeing is a takeover. A takeover of control while keeping the shareholders on the hook for capital mining at a later date.

Whether this was by design or not who knows. But what is sure is this has been subject to a pump and dump strategy from the start.

Glad I don't have a single bean invested with it. And I still managed to make a few bucks along the way. Thanks Mr. Streeter.



--------------------
What did Uncle Mel do to us?
 
 


6 Pages (Click to Jump) V   1 2 3 4 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING